Dr. DiBattista is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S Maryland Ave
MC4076
Chicago, IL 60637
Education & Training
University of ChicagoFellowship, Gastroenterology, 2022
University of MichiganResidency, Internal Medicine, 2019 - 2022
Rush Medical College of Rush University Medical CenterClass of 2019
Certifications & Licensure
IL State Medical License 2022 - 2026
MI State Medical License 2019 - 2021- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Successful Treatment of Refractory Chylous Ascites With Octreotide in a Patient With Decompensated Cirrhosis.Jacob V DiBattista, Matthew A Odenwald, Helen Te
ACG Case Reports Journal. 2024-04-01 - 5 citationsProgression to cirrhosis is similar among all ages in nonalcoholic fatty liver disease, but liver-related events increase with age.Matthew J Miller, Emily Harding-Theobald, Jacob V DiBattista, Zhe Zhao, Karn Wijarnpreecha
Hepatology Communications. 2023-06-01 - 1 citationsLong-term weight changes are associated with initial weight changes after nonalcoholic fatty liver disease diagnosis.Jacob V DiBattista, Anna S Lok, Vincent L Chen
Hepatology Communications. 2023-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
